NSAID Safety in Pregnancy
NSAIDs can be used cautiously during early-to-mid pregnancy at the lowest effective dose for the shortest duration, but must be discontinued by 30 weeks gestation (6-8 weeks before term) to avoid serious fetal complications including premature ductus arteriosus closure, oligohydramnios, and pulmonary hypertension 1.
Critical Timing Considerations
Preconception and First Trimester
- Women actively trying to conceive should avoid NSAIDs entirely, as animal models demonstrate these drugs can block blastocyst implantation 1
- First trimester exposure carries a 28% increased risk of overall congenital anomalies (OR 1.28,95% CI 1.16-1.40) and 19% increased risk of major birth defects (OR 1.19,95% CI 1.08-1.30) 2
- Risk of spontaneous abortion is significantly elevated with NSAID use (OR 2.43,95% CI 2.12-2.79), affecting all common NSAIDs including diclofenac (OR 3.09), naproxen (OR 2.64), ibuprofen (OR 2.19), and celecoxib (OR 2.21) 3
Second Trimester
- Short-term use (<7 days) for analgesia or fever appears relatively safe based on limited case reports 4
- Long-term use in late second trimester requires ultrasound monitoring for oligohydramnios and ductus arteriosus constriction 4
Third Trimester (After 30 Weeks)
- Absolute contraindication for routine use 1
- Must discontinue 6-8 weeks before term to prevent serious complications
Specific Fetal/Neonatal Risks Near Term
When NSAIDs are used close to delivery, the following complications occur through prostaglandin inhibition:
Cardiovascular:
- Premature closure of ductus arteriosus
- Pulmonary hypertension
- Increased cutaneous and intracranial bleeding
Renal:
- Impaired renal function
- Reduced urine output
- Oligohydramnios (reversible upon discontinuation) 5
Maternal:
- Prolonged gestation and labor
- Increased peripartum blood loss
- Increased anemia
These effects have been documented with indomethacin, naproxen, ketoprofen, and ibuprofen 1, 6.
Clinical Algorithm for NSAID Use
If NSAID therapy is being considered:
- Gestational age <30 weeks AND not actively trying to conceive: May use at lowest effective dose for shortest duration (ideally <7 days)
- Gestational age ≥30 weeks: Do not prescribe NSAIDs
- If treatment >48 hours is needed: Perform ultrasound monitoring of amniotic fluid index (AFI) and stop therapy if AFI declines 5
- Long-term use in second trimester: Monitor for oligohydramnios and ductus arteriosus constriction with serial ultrasounds 4
Important Caveats
While guidelines state NSAIDs are "not known to be teratogenic in humans" 1, this conflicts with more recent meta-analysis data showing increased congenital anomaly risk 2. The weight of evidence now suggests first trimester exposure does carry measurable teratogenic risk, making acetaminophen the preferred first-line analgesic throughout pregnancy.
The guideline evidence is from 2009 and predates the 2024 systematic review demonstrating significant congenital anomaly risks 2. This represents an important evolution in our understanding of NSAID safety.
Low-Dose Aspirin Exception
Low-dose aspirin (typically 81mg daily) is considered safe throughout pregnancy for specific indications like preeclampsia prevention and does not increase maternal or neonatal morbidity or mortality 1. This is distinct from therapeutic NSAID dosing.
Breastfeeding
The American Academy of Pediatrics considers ibuprofen, indomethacin, and naproxen safe during breastfeeding, with only trace amounts in breast milk 1. Contraindication exists when breastfeeding a neonate with jaundice due to bilirubin displacement. Avoid large doses of aspirin due to salicylate intoxication and bleeding risks 1.